Drug
roflumilast
Marketed as ZORYVE.
Generic name
roflumilast
Brand names
ZORYVE
First FDA approval
2022-07-29
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA215985 | ZORYVE | 2022-07-29 | ARCUTIS |
Manufacturers
ARCUTIS
Frequently asked questions
When was roflumilast FDA approved?
Earliest FDA approval on record: 2022-07-29.
What brand names are sold as roflumilast?
ZORYVE.
Sources
Appeal a roflumilast denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com